Systematic Review

Published on 07 Dec 2023

Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials

in Inflammation Pharmacology

Liuting Zeng
Qi He
Ying Deng
Yuwei Li
Junpeng Chen
Kailin Yang
Yanfang Luo
Anqi Ge
Xiaofei Zhu
Zhiyong Long

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1189142

3,443 views
3 citations

Editorial

Published on 06 Dec 2023

Editorial: Lipidomics of oxylipins in biological systems

in Inflammation Pharmacology

Paola Patrignani
Nils Helge Schebb
Oliver Werz
Dieter Steinhilber

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1342596

1,359 views

Original Research

Published on 29 Nov 2023

ACT001 improved cardiovascular function in septic mice by inhibiting the production of proinflammatory cytokines and the expression of JAK-STAT signaling pathway

in Inflammation Pharmacology

Zhen Peng
Xiaolong Lv
Xintong Wang
Ting Shang
Jing Chang
Khalid Salahdiin
Yue Guo
Zhisen Zhang
Ru Shen
Ming Lyu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265177

2,862 views
1 citation

Original Research

Published on 20 Nov 2023

IL-37 counteracts inflammatory injury in the temporomandibular joint via the intracellular pathway

in Inflammation Pharmacology

Jun Li
Sisi Peng
Ying Yan
Shan Yan
Xin Cao
Yong Li
Luying Zhu
Jie Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1250216

1,689 views

Review

Published on 16 Nov 2023

Current and promising therapies based on the pathogenesis of Graves’ ophthalmopathy

in Inflammation Pharmacology

Xin Zhang
Qixiang Zhao
Bei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1217253

4,072 views
3 citations

Review

Published on 15 Nov 2023

Immunomodulatory roles of metalloproteinases in rheumatoid arthritis

in Inflammation Pharmacology

Yanqin Bian
Zheng Xiang
Yaofeng Wang
Qing Ren
Guoming Chen
Bei Xiang
Jianye Wang
Chengbo Zhang
Shaoqiang Pei
Shicheng Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1285455

5,418 views
9 citations

Original Research

Published on 10 Nov 2023

Suppression of inflammation-induced lung cancer cells proliferation and metastasis by exiguaflavanone A and exiguaflavanone B from Sophora exigua root extract through NLRP3 inflammasome pathway inhibition

in Inflammation Pharmacology

Punnida Arjsri
Kamonwan Srisawad
Warathit Semmarath
Sonthaya Umsumarng
Lapamas Rueankham
Aroonchai Saiai
Methee Rungrojsakul
Trinnakorn Katekunlaphan
Songyot Anuchapreeda
Pornngarm Dejkriengkraikul

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1243727

2,058 views
3 citations

Mini Review

Published on 06 Nov 2023

Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review

in Inflammation Pharmacology

Qiang Cao
Xinyan Wu
Qi Zhang
Junling Gong
Yuquan Chen
Yanwei You
Jun Shen
Yi Qiang
Guangzhu Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1291920

4,943 views
15 citations

Mini Review

Published on 06 Nov 2023

Role of signaling lymphocytic activation molecule family of receptors in the pathogenesis of rheumatoid arthritis: insights and application

in Inflammation Pharmacology

Yixin Zheng
Jianan Zhao
Mi Zhou
Kai Wei
Ping Jiang
Lingxia Xu
Cen Chang
Yu Shan
Linshuai Xu
Yiming Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1306584

2,629 views
3 citations

Brief Research Report

Published on 01 Nov 2023

Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5)

in Inflammation Pharmacology

Remy Bonnavion
Shangmin Liu
Haruya Kawase
Kenneth Anthony Roquid
Stefan Offermanns

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1297596

2,345 views
2 citations

Original Research

Published on 30 Oct 2023

Association of lipid lowering drugs and the risk of systemic lupus erythematosus: a drug target Mendelian randomization

in Inflammation Pharmacology

Tong Wu
Ling Ye
Shenglan Wang
Jie Huang
Jing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1258018

4,595 views
2 citations

Original Research

Published on 26 Oct 2023

β-sitosterol alleviates dextran sulfate sodium-induced experimental colitis via inhibition of NLRP3/Caspase-1/GSDMD-mediated pyroptosis

in Inflammation Pharmacology

Di Zhang
Fei Ge
Jing Ji
Yu-Jing Li
Fu-Rong Zhang
Shu-Yan Wang
Shu-Jing Zhang
Dong-Mei Zhang
Meng Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1218477

3,501 views
7 citations

Correction

Published on 26 Oct 2023

Corrigendum: Naringenin protects against acute pancreatitis-associated intestinal injury by inhibiting NLRP3 inflammasome activation via AhR signaling

in Inflammation Pharmacology

Xu Yan
Tianjiao Lin
Qingyun Zhu
Yushi Zhang
Zhimin Song
Xinting Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1295494

785 views
4 citations

Opinion

Published on 23 Oct 2023

Whether MTHFD2 plays a new role: from anticancer targets to anti-inflammatory disease

in Inflammation Pharmacology

Hui Tang
Ning Hou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1257107

1,696 views

Original Research

Published on 23 Oct 2023

Non-aromatizable androgens modulate the lipopolysaccharide induced expression of the P2X7 receptor in human adipocytes

in Inflammation Pharmacology

Angelo Di Vincenzo
Marnie Granzotto
Marika Crescenzi
Roberto Vettor
Marco Rossato

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1251035

1,286 views

Editorial

Published on 17 Oct 2023

Editorial: Global excellence in inflammation pharmacology

in Inflammation Pharmacology

Sukanya Saha
Shatadal Ghosh

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1307503

1,828 views

Navigation group

Articles

Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials

Editorial: Lipidomics of oxylipins in biological systems

ACT001 improved cardiovascular function in septic mice by inhibiting the production of proinflammatory cytokines and the expression of JAK-STAT signaling pathway

IL-37 counteracts inflammatory injury in the temporomandibular joint via the intracellular pathway

Current and promising therapies based on the pathogenesis of Graves’ ophthalmopathy

Immunomodulatory roles of metalloproteinases in rheumatoid arthritis

Suppression of inflammation-induced lung cancer cells proliferation and metastasis by exiguaflavanone A and exiguaflavanone B from Sophora exigua root extract through NLRP3 inflammasome pathway inhibition

Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review

Role of signaling lymphocytic activation molecule family of receptors in the pathogenesis of rheumatoid arthritis: insights and application

Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5)

Association of lipid lowering drugs and the risk of systemic lupus erythematosus: a drug target Mendelian randomization

β-sitosterol alleviates dextran sulfate sodium-induced experimental colitis via inhibition of NLRP3/Caspase-1/GSDMD-mediated pyroptosis

Corrigendum: Naringenin protects against acute pancreatitis-associated intestinal injury by inhibiting NLRP3 inflammasome activation via AhR signaling

Whether MTHFD2 plays a new role: from anticancer targets to anti-inflammatory disease

Non-aromatizable androgens modulate the lipopolysaccharide induced expression of the P2X7 receptor in human adipocytes

Editorial: Global excellence in inflammation pharmacology